Stock News

Cosmos Health Inc. Regains Compliance with Nasdaq Listing Rule August 23, 2024 – Chicago, IL Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a leader in the healthcare industry Cosmos Health Inc., a diversified, vertically integrated global healthcare group, has announced that the Company has regained compliance with Listing Rule 5250(c)(1) in connection with…

Validation Studies Confirmed the Assay Can Detect Mpox Clade I and Clade Ib in addition to Clade II STONY BROOK, NY / ACCESSWIRE / August 23, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted…

Teledyne Brown Engineering Awarded $114 Million Contract by U.S. Army Introduction Teledyne Brown Engineering, a subsidiary of Teledyne Technologies Incorporated, has been awarded a $114 million Task Order under the Design, Development, Demonstration, and Integration (D3I) Domain 1 contract by the U.S. Army Space and Missile Defense Command. This task order will involve the design,…

Charmingly Eccentric Blog Post Article The Unique Appeal of Charmingly Eccentric Content When it comes to capturing the attention of readers, there is something undeniably special about content that is charm…surfing blog post article on a lazy Sunday afternoon. It’s the quirky anecdotes and unexpected tangents that keep readers coming back for more. So embrace…

The Tinley Beverage Company Inc. Provides Update on Private Placement and Debt Settlement Transactions Toronto, Ontario and Los Angeles, California–(Newsfile Corp. – August 23, 2024) The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB: TNYBF) (“Tinley’s” or the “Company”) has announced an update on its previously announced private placement (the “Private Placement”) and debt settlement (the…

OKYO Pharma Limited Announces Share Purchase by Executive Chairman London and New York, Aug. 23, 2024 OKYO Pharma Limited (NASDAQ: OKYO) – A Clinical-Stage Biopharmaceutical Company OKYO Pharma Limited, a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED) and anterior ocular segment diseases including neuropathic corneal pain…

XORTX Therapeutics Inc. Announces Release of Management Information Circular Calgary, Alberta, Aug. 23, 2024 (GLOBE NEWSWIRE) XORTX Therapeutics Inc. (“XORTX” or the “Company”) is a leading pharmaceutical company specializing in the development of innovative therapies for progressive kidney disease. The Company has recently announced the availability of the management information circular for its upcoming annual…

Nuveen Real Asset Income and Growth Fund: A Closer Look Introduction The Nuveen Real Asset Income and Growth Fund is a closed-end fund that focuses on providing exposure to ‘real assets’ such as real estate and infrastructure. This unique investment opportunity offers investors a chance to diversify their portfolio and potentially earn a high yield…